Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Sundaram G, Kothari S, Voleti S, Krishna V, Bose J. Type C1 radical hysterectomy in advanced squamous cell carcinoma of the cervix postdefinitive concurrent chemoradiation: an argument. J Cancer Res Ther. 2022;18(6):1559.
2. Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N. Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv72-83.
3. Sathishkumar K, Chaturvedi M, Das P, Stephen S, Mathur P (2023) Cancer incidence estimates for 2022 & projection for 2025: Result from National Cancer Registry Programme India. Indian J Med Res
4. Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncol. 2008;9(3):297–303.
5. Sardain H, Lavoue V, Redpath M, Bertheuil N, Foucher F, Levêque J. Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review. Eur J Surg Oncol EJSO. 2015;41(8):975–85.